Follow RSS for latest reports on this topicPricing - Market Research and Reports

Poliomyelitis - Pricing & Market Access and Landscape- 2019

Firstview Insight's Poliomyelitis - Pricing & Market Access and Landscape- 2019 provides country specific insights in order to estimate market potential for Poliomyelitis based on the pricing and reimbursement scenario and perceived value drivers in different market archetypes. It gives a detailed picture of the disease landscape and unmet needs of different stakeholders existing in the current ...Read More >>>

Published:
2019-12-27

Published by: First View Insight

Prices Starting From:
$2500

Wet AMD - Pricing & Market Access and Landscape- 2019

Firstview Insight's Wet AMD - Pricing & Market Access and Landscape- 2019 provides country specific insights in order to estimate market potential for Wet AMD based on the pricing and reimbursement scenario and perceived value drivers in different market archetypes. It gives a detailed picture of the disease landscape and unmet needs of different stakeholders existing in the current treatment para...Read More >>>

Published:
2019-12-20

Published by: First View Insight

Prices Starting From:
$2500

AlphaMannosidosis - Pricing & Market Access and Landscape- 2019

Firstview Insight's AlphaMannosidosis - Pricing & Market Access and Landscape- 2019 provides country specific insights in order to estimate market potential for AlphaMannosidosis based on the pricing and reimbursement scenario and perceived value drivers in different market archetypes. It gives a detailed picture of the disease landscape and unmet needs of different stakeholders existing in the ...Read More >>>

Published:
2019-12-08

Published by: First View Insight

Prices Starting From:
$2500

Depression-Pricing & Market Access and Landscape- 2019

Firstview Insight's Depression-Pricing & Market Access and Landscape- 2019 provides country specific insights in order to estimate market potential for Depression based on the pricing and reimbursement scenario and perceived value drivers in different market archetypes. It gives a detailed picture of the disease landscape and unmet needs of different stakeholders existing in the current treatment ...Read More >>>

Published:
2019-11-15

Published by: First View Insight

Prices Starting From:
$2500

Hemophilia-Pricing & Market Access and Landscape- 2019

Firstview Insight's Hemophilia-Pricing & Market Access and Landscape- 2019 provides country specific insights in order to estimate market potential for Hemophilia based on the pricing and reimbursement scenario and perceived value drivers in different market archetypes. It gives a detailed picture of the disease landscape and unmet needs of different stakeholders existing in the current treatment ...Read More >>>

Published:
2019-11-15

Published by: First View Insight

Prices Starting From:
$2500

Epilepsy-Pricing & Market Access and Landscape- 2019

Firstview Insight's Epilepsy-Pricing & Market Access and Landscape- 2019 provides country specific insights in order to estimate market potential for Epilepsy based on the pricing and reimbursement scenario and perceived value drivers in different market archetypes. It gives a detailed picture of the disease landscape and unmet needs of different stakeholders existing in the current treatment para...Read More >>>

Published:
2019-11-15

Published by: First View Insight

Prices Starting From:
$2500

Influenza-Pricing & Market Access and Landscape- 2019

Firstview Insight's Influenza-Pricing & Market Access and Landscape- 2019 provides country specific insights in order to estimate market potential for Influenza based on the pricing and reimbursement scenario and perceived value drivers in different market archetypes. It gives a detailed picture of the disease landscape and unmet needs of different stakeholders existing in the current treatment pa...Read More >>>

Published:
2019-11-15

Published by: First View Insight

Prices Starting From:
$2500

NSCLC-Pricing & Market Access and Landscape- 2019

Firstview Insight's NSCLC-Pricing & Market Access and Landscape- 2019 provides country specific insights in order to estimate market potential for NSCLC based on the pricing and reimbursement scenario and perceived value drivers in different market archetypes. It gives a detailed picture of the disease landscape and unmet needs of different stakeholders existing in the current treatment paradigmTh...Read More >>>

Published:
2019-11-15

Published by: First View Insight

Prices Starting From:
$2500

Schizophrenia-Pricing & Market Access and Landscape- 2019

Firstview Insight's Schizophrenia-Pricing & Market Access and Landscape- 2019 provides country specific insights in order to estimate market potential for Schizophrenia based on the pricing and reimbursement scenario and perceived value drivers in different market archetypes. It gives a detailed picture of the disease landscape and unmet needs of different stakeholders existing in the current trea...Read More >>>

Published:
2019-11-15

Published by: First View Insight

Prices Starting From:
$2500

Glaucoma-Pricing & Market Access and Landscape- 2019

Firstview Insight's Glaucoma-Pricing & Market Access and Landscape- 2019 provides country specific insights in order to estimate market potential for Glaucoma based on the pricing and reimbursement scenario and perceived value drivers in different market archetypes. It gives a detailed picture of the disease landscape and unmet needs of different stakeholders existing in the current treatment para...Read More >>>

Published:
2019-11-15

Published by: First View Insight

Prices Starting From:
$2500

Acute Lymphoblastic Leukemia - Pricing and Market Access

Firstview Insight's Acute Lymphoblastic Leukemia - Pricing and Market Access provides country specific insights in order to estimate market potential for Acute Lymphoblastic Leukemia based on the pricing and reimbursement scenario and perceived value drivers in different market archetypes. It gives a detailed picture of the disease landscape and unmet needs of different stakeholders existing in ...Read More >>>

Published:
2019-11-15

Published by: First View Insight

Prices Starting From:
$2500

Acute Myeloid Leukemia - Pricing and Market Access

Firstview Insight's Acute Myeloid Leukemia - Pricing and Market Access provides country specific insights in order to estimate market potential for Acute Myeloid Leukemia based on the pricing and reimbursement scenario and perceived value drivers in different market archetypes. It gives a detailed picture of the disease landscape and unmet needs of different stakeholders existing in the current ...Read More >>>

Published:
2019-11-15

Published by: First View Insight

Prices Starting From:
$2500

Age related macular degeneration - Pricing and Market Access

Firstview Insight's Age related macular degeneration - Pricing and Market Access provides country specific insights in order to estimate market potential for Age related macular degeneration based on the pricing and reimbursement scenario and perceived value drivers in different market archetypes. It gives a detailed picture of the disease landscape and unmet needs of different stakeholders existi...Read More >>>

Published:
2019-11-15

Published by: First View Insight

Prices Starting From:
$2500

Allergic Conjunctivitis - Pricing and Market Access

Firstview Insight's Allergic Conjunctivitis - Pricing and Market Access provides country specific insights in order to estimate market potential for Allergic Conjunctivitis based on the pricing and reimbursement scenario and perceived value drivers in different market archetypes. It gives a detailed picture of the disease landscape and unmet needs of different stakeholders existing in the curren...Read More >>>

Published:
2019-11-15

Published by: First View Insight

Prices Starting From:
$2500

Alopecia Areata - Pricing and Market Access

Firstview Insight's Alopecia Areata - Pricing and Market Access provides country specific insights in order to estimate market potential for Alopecia Areata based on the pricing and reimbursement scenario and perceived value drivers in different market archetypes. It gives a detailed picture of the disease landscape and unmet needs of different stakeholders existing in the current treatment paradi...Read More >>>

Published:
2019-11-15

Published by: First View Insight

Prices Starting From:
$2500

Alpha Antitrypsin Deficiency - Pricing and Market Access

Firstview Insight's Alpha Antitrypsin Deficiency - Pricing and Market Access provides country specific insights in order to estimate market potential for Alpha Antitrypsin Deficiency based on the pricing and reimbursement scenario and perceived value drivers in different market archetypes. It gives a detailed picture of the disease landscape and unmet needs of different stakeholders existing in ...Read More >>>

Published:
2019-11-15

Published by: First View Insight

Prices Starting From:
$2500

Alpha Thalassemia - Pricing and Market Access

Firstview Insight's Alpha Thalassemia - Pricing and Market Access provides country specific insights in order to estimate market potential for Alpha Thalassemia based on the pricing and reimbursement scenario and perceived value drivers in different market archetypes. It gives a detailed picture of the disease landscape and unmet needs of different stakeholders existing in the current treatment ...Read More >>>

Published:
2019-11-15

Published by: First View Insight

Prices Starting From:
$2500

Amyloidosis - Pricing and Market Access

Firstview Insight's Amyloidosis - Pricing and Market Access provides country specific insights in order to estimate market potential for Amyloidosis based on the pricing and reimbursement scenario and perceived value drivers in different market archetypes. It gives a detailed picture of the disease landscape and unmet needs of different stakeholders existing in the current treatment paradigmThus...Read More >>>

Published:
2019-11-15

Published by: First View Insight

Prices Starting From:
$2500

Amyotrophic lateral sclerosis - Pricing and Market Access

Firstview Insight's Amyotrophic lateral sclerosis - Pricing and Market Access provides country specific insights in order to estimate market potential for Amyotrophic lateral sclerosis based on the pricing and reimbursement scenario and perceived value drivers in different market archetypes. It gives a detailed picture of the disease landscape and unmet needs of different stakeholders existing i...Read More >>>

Published:
2019-11-15

Published by: First View Insight

Prices Starting From:
$2500

Anal Cancer - Pricing and Market Access

Firstview Insight's Anal Cancer - Pricing and Market Access provides country specific insights in order to estimate market potential for Anal Cancer based on the pricing and reimbursement scenario and perceived value drivers in different market archetypes. It gives a detailed picture of the disease landscape and unmet needs of different stakeholders existing in the current treatment paradigmThus...Read More >>>

Published:
2019-11-15

Published by: First View Insight

Prices Starting From:
$2500

Anaplastic Astrocytoma - Pricing and Market Access

Firstview Insight's Anaplastic Astrocytoma - Pricing and Market Access provides country specific insights in order to estimate market potential for Anaplastic Astrocytoma based on the pricing and reimbursement scenario and perceived value drivers in different market archetypes. It gives a detailed picture of the disease landscape and unmet needs of different stakeholders existing in the current ...Read More >>>

Published:
2019-11-15

Published by: First View Insight

Prices Starting From:
$2500

Atopic Dermatitis - Pricing and Market Access

Firstview Insight's Atopic Dermatitis - Pricing and Market Access provides country specific insights in order to estimate market potential for Atopic Dermatitis based on the pricing and reimbursement scenario and perceived value drivers in different market archetypes. It gives a detailed picture of the disease landscape and unmet needs of different stakeholders existing in the current treatment pa...Read More >>>

Published:
2019-11-15

Published by: First View Insight

Prices Starting From:
$2500

Behcets Disease - Pricing and Market Access

Firstview Insight's Behcets Disease - Pricing and Market Access provides country specific insights in order to estimate market potential for Behcets Disease based on the pricing and reimbursement scenario and perceived value drivers in different market archetypes. It gives a detailed picture of the disease landscape and unmet needs of different stakeholders existing in the current treatment para...Read More >>>

Published:
2019-11-15

Published by: First View Insight

Prices Starting From:
$2500

Beta Thalassemia - Pricing and Market Access

Firstview Insight's Beta Thalassemia - Pricing and Market Access provides country specific insights in order to estimate market potential for Beta Thalassemia based on the pricing and reimbursement scenario and perceived value drivers in different market archetypes. It gives a detailed picture of the disease landscape and unmet needs of different stakeholders existing in the current treatment pa...Read More >>>

Published:
2019-11-15

Published by: First View Insight

Prices Starting From:
$2500

Bipolar Disorder - Pricing and Market Access

Firstview Insight's Bipolar Disorder - Pricing and Market Access provides country specific insights in order to estimate market potential for Bipolar Disorder based on the pricing and reimbursement scenario and perceived value drivers in different market archetypes. It gives a detailed picture of the disease landscape and unmet needs of different stakeholders existing in the current treatment para...Read More >>>

Published:
2019-11-15

Published by: First View Insight

Prices Starting From:
$2500

Bronchopulmonary Dysplasia - Pricing and Market Access

Firstview Insight's Bronchopulmonary Dysplasia - Pricing and Market Access provides country specific insights in order to estimate market potential for Bronchopulmonary Dysplasia based on the pricing and reimbursement scenario and perceived value drivers in different market archetypes. It gives a detailed picture of the disease landscape and unmet needs of different stakeholders existing in the ...Read More >>>

Published:
2019-11-15

Published by: First View Insight

Prices Starting From:
$2500

Colorectal cancer - Pricing and Market Access

Firstview Insight's Colorectal cancer - Pricing and Market Access provides country specific insights in order to estimate market potential for Colorectal cancer based on the pricing and reimbursement scenario and perceived value drivers in different market archetypes. It gives a detailed picture of the disease landscape and unmet needs of different stakeholders existing in the current treatment pa...Read More >>>

Published:
2019-11-15

Published by: First View Insight

Prices Starting From:
$2500

Cystic fibrosis - Pricing and Market Access

Firstview Insight's Cystic fibrosis - Pricing and Market Access provides country specific insights in order to estimate market potential for Cystic fibrosis based on the pricing and reimbursement scenario and perceived value drivers in different market archetypes. It gives a detailed picture of the disease landscape and unmet needs of different stakeholders existing in the current treatment para...Read More >>>

Published:
2019-11-15

Published by: First View Insight

Prices Starting From:
$2500

Ewing Sarcoma - Pricing and Market Access

Firstview Insight's Ewing Sarcoma - Pricing and Market Access provides country specific insights in order to estimate market potential for Ewing Sarcoma based on the pricing and reimbursement scenario and perceived value drivers in different market archetypes. It gives a detailed picture of the disease landscape and unmet needs of different stakeholders existing in the current treatment paradigm...Read More >>>

Published:
2019-11-15

Published by: First View Insight

Prices Starting From:
$2500

Myelodysplastic Syndrome - Pricing and Market Access

Firstview Insight's Myelodysplastic Syndrome - Pricing and Market Access provides country specific insights in order to estimate market potential for Myelodysplastic Syndrome based on the pricing and reimbursement scenario and perceived value drivers in different market archetypes. It gives a detailed picture of the disease landscape and unmet needs of different stakeholders existing in the curr...Read More >>>

Published:
2019-11-15

Published by: First View Insight

Prices Starting From:
$2500

Keratoconjunctivitis sicca (Dry Eye) - Pricing and Market Access

Firstview Insight's Latestage chronic kidney disease (CKD) - Pricing and Market Access provides country specific insights in order to estimate market potential for Latestage chronic kidney disease (CKD) based on the pricing and reimbursement scenario and perceived value drivers in different market archetypes. It gives a detailed picture of the disease landscape and unmet needs of different stake...Read More >>>

Published:
2019-11-15

Published by: First View Insight

Prices Starting From:
$2500

Liver cancer - Pricing and Market Access

Firstview Insight's Macular Edema - Pricing and Market Access provides country specific insights in order to estimate market potential for Macular Edema based on the pricing and reimbursement scenario and perceived value drivers in different market archetypes. It gives a detailed picture of the disease landscape and unmet needs of different stakeholders existing in the current treatment paradigm...Read More >>>

Published:
2019-11-15

Published by: First View Insight

Prices Starting From:
$2500

Macular Edema - Pricing and Market Access

Firstview Insight's Major depressive disorder - Pricing and Market Access provides country specific insights in order to estimate market potential for Major depressive disorder based on the pricing and reimbursement scenario and perceived value drivers in different market archetypes. It gives a detailed picture of the disease landscape and unmet needs of different stakeholders existing in the curr...Read More >>>

Published:
2019-11-15

Published by: First View Insight

Prices Starting From:
$2500

Medulloblastoma - Pricing and Market Access

Firstview Insight's Merkel Cell Carcinoma - Pricing and Market Access provides country specific insights in order to estimate market potential for Merkel Cell Carcinoma based on the pricing and reimbursement scenario and perceived value drivers in different market archetypes. It gives a detailed picture of the disease landscape and unmet needs of different stakeholders existing in the current trea...Read More >>>

Published:
2019-11-15

Published by: First View Insight

Prices Starting From:
$2500

Pricing and Reimbursement in Oncology -- Payer views

As payer and stakeholder anger mounts, when will the oncology drug price bubble burst? Global cancer drug prices have increased by 10% every year between 1995 and 2013. That level of price inflation is not sustainable or winning pharma any friends. In this expert report, US and EU payers note that monopolistic pricing for novel products that represent the only therapeutic option, or the high price...Read More >>>

Published:
2018-01-01

Published by: FirstWord Pharma

Prices Starting From:
$2375

Pricing and Reimbursement in Neurology -- Payer views

When first line treatments for neurological diseases such as Parkinson's Disease (PD) and Multiple Sclerosis (MS) have been around for years, it's understandable that when something new is approved, people want to try it. So, just how serious a stumbling block is the price gap between old and new proving to be for payers in the US and EU? Are pharma's pricing justifications believed and accepted? ...Read More >>>

Published:
2018-01-01

Published by: FirstWord Pharma

Prices Starting From:
$2375

Payer attitudes to Orphan Drug pricing

Payer Attitudes to Orphan Drug FundingThe explosion of orphan drugs across Europe and the US is pushing healthcare finances towards breaking point according to payers. Requests for orphan drug designation have reached unprecedented levels and the high cost of these specialist treatments is swallowing up a larger and larger share of the drug funding pot. Payers are not happy and clearly something n...Read More >>>

Published:
2017-08-01

Published by: FirstWord Pharma

Prices Starting From:
$2245

Innovations in Drug Pricing and Reimbursement (2016)

IntroductionIs the drug pricing bubble about to burst?Drug costs are becoming unaffordable and draconian cost containment strategies are being employed.The pharma industry is winning few friends when it comes to drug pricing. Public, health professional, political and payer hostility is growing worldwide as the prices of new drugs for chronic disease, specialty medicines and even generics grow ex...Read More >>>

Published:
2016-02-01

Published by: FirstWord Pharma

Prices Starting From:
$2195

Trends and Innovations in Drug Pricing

IntroductionFirstWord’s Trends and Innovations in Drug Pricing report dissects international trends and examines how long-standing dynamics in competitive pricing and access will strengthen the payer position in demanding discounts in return for guaranteed patient access. Up-to-the-minute and based on the most current research and expert interviews, Trends and Innovations in Drug Pricing is an o...Read More >>>

Published:
2015-01-01

Published by: FirstWord Pharma

Prices Starting From:
$695

Tiered Pricing Strategies in Emerging Markets

IntroductionFor the pharmaceutical industry, emerging markets are dynamic, full of potential and offer solid growth at a time when established markets are contracting. But they also pose a significant problem: extreme disparities in income. Increasingly, companies are turning to tiered pricing as a solution. The strategy targets market segments, boosts market share and increases patient access to ...Read More >>>

Published:
2012-02-01

Published by: FirstWord Pharma

Prices Starting From:
$695